Immunization News and Research

RSS

Medical societies unify to endorse evidence-based respiratory vaccine guidance

Hoping to provide much-needed guidance to clinicians treating patients with lung disease and to promote respiratory health, the Vaccine Guidance Review Panel, a multi-medical society effort, announced its endorsement of influenza, RSV and COVID-19 recommendations for adults and children.

5 Nov 2026

FDA approves ILUMYA for adults with active psoriatic arthritis

Sun Pharmaceutical Industries Limited announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ILUMYA® (tildrakizumab-asmn) for the treatment of adults with active psoriatic arthritis (PsA).

30 Oct 2026

AGS initiative targets gaps in older adults' vaccination rates

Today, the American Geriatrics Society (AGS) released a paper in the Journal of the American Geriatrics Society detailing findings from the AGS Older Adults Vaccine (AGS OAV) Initiative (https://doi.org/10.1111/jgs.70770).

28 Oct 2026

Breast milk antibodies show promise against multiple respiratory viruses

Yona Tugg and colleagues show that a polyclonal secretory immunoglobulin A preparation, purified from breast milk pooled from multiple donors, neutralized respiratory syncytial virus (RSV), human adenovirus type 5, and H1N1 and H3N2 influenza A viruses in laboratory assays.

14 Oct 2026

Ebola vaccine triggers cross reactive T cells against Bundibugyo ebolavirus

The ongoing Bundibugyo ebolavirus (BDBV) outbreak in the Democratic Republic of the Congo is the second-largest Ebolavirus outbreak globally, with more than 6,000 confirmed cases and a mortality rate of 48 percent.

14 Oct 2026

New review highlights expanding potential of therapeutic DNA vaccines

A new review published in Genes & Diseases highlights the expanding potential of DNA-based vaccines as a flexible platform for preventing infectious diseases, treating cancer and strengthening preparedness for future disease outbreaks.

12 Oct 2026

Type 1 diabetes incidence rose by 11% after rotavirus vaccine rollout in Norway

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in Diabetologia (the journal of EASD) shows that incidence (the new case rate) of type 1 diabetes (T1D) in children aged 0.5-5 years in Norway was 11% higher following the rapid roll out and uptake of the rotavirus vaccine in September 2014.

1 Oct 2026

Measles outbreaks may reveal more than gaps in vaccination

A commentary in Human Vaccines & Immunotherapeutics argues that measles outbreaks can serve as a sensitive indicator of weaknesses in vaccination coverage, surveillance, health equity, community trust, and broader immunization systems. The authors contend that pursuing measles eradication could also strengthen routine immunization, laboratory capacity, outbreak preparedness, and health-system resilience.

21 Sep 2026

A 194-country analysis reveals gaps in how late childhood vaccinations are tracked

A global analysis of WHO/UNICEF data from 194 countries found wide variation in countries’ ability to record delayed childhood vaccinations, with 64% of reporting countries saying they could capture late doses in 2022. Following birth cohorts over time and adding delayed MCV1 doses raised median coverage estimates by 3.6 to 5.1 percentage points across available cohort years, though incomplete and inconsistent reporting limited confidence in some estimates.

21 Sep 2026

Chile becomes first South American nation to eliminate dog-transmitted rabies

Chile has become the first country in South America to receive the World Health Organization (WHO) validation for eliminating dog-transmitted rabies as a public health problem.

18 Sep 2026

Independent review reinforces value of vaccines across all ages

The Gerontological Society of America (GSA) supports the 2026-27 respiratory season vaccine evidence review released on September 2, 2026, by the Vaccine Integrity Project (VIP) in collaboration with the American Medical Association.

4 Sep 2026

Mosaic nanoparticle vaccine boosts broad mucosal coronavirus immunity

The persistent threat of emerging coronaviruses highlights the critical need to establish frontline defenses directly at the respiratory entry portal.

4 Sep 2026

PAHO/WHO assists Colombia with recovery following major earthquake

The Pan American Health Organization (PAHO), Regional Office for the Americas of the World Health Organization (WHO), is providing technical cooperation to Colombian authorities to support the health response following the magnitude 7.4 earthquake that struck western Colombia on August 10.

25 Aug 2026

Yeast-based nanoparticle vaccine could make annual flu shots obsolete

The world mostly relies on an 80-year-old method for producing flu vaccines from chicken eggs - a slow, costly process that struggles to quickly adapt to new, mutant strains.

24 Aug 2026

New review examines why tetanus remains a global health problem

Tetanus is often considered a disease of the past, remembered mainly through childhood vaccinations and warnings about rusty nails.

20 Aug 2026

Why pregnancy vaccination looks very different in Germany than it did 19 years ago

A 19-year German claims analysis of more than 2.8 million pregnancies found that recorded maternal vaccination increased substantially after national recommendations for influenza and pertussis immunization were introduced. Influenza vaccination reached 19.4% and pertussis vaccination about 37% in 2020-2022, while COVID-19 vaccination was not captured in the databas

19 Aug 2026